Experimental injection tested for debilitating muscle disease
NCT ID NCT06965309
Summary
This early-stage study tested an experimental injection called HN2301 in a small group of adults with severe, hard-to-treat myasthenia gravis. The main goal was to check if the treatment was safe and tolerable. Researchers also looked for early signs that it could help improve patients' muscle weakness and daily activities.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY MYASTHENIA GRAVIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai General Hospital (Songjiang Branch) of Shanghai Jiao Tong University School of Medicine
Shanghai, 201600, China
Conditions
Explore the condition pages connected to this study.